« Back to Record
Citation APA

Nanda, R., Chow, L. Q. M. L., Claire Dees, E., Berger, R., Gupta, S., Geva, R., Pusztai, L., Pathiraja, K., Aktan, G., Cheng, J. D., Karantza, V., & Buisseret, L. (2016). Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study. Journal of clinical oncology, 34(21), 2460-2467. doi:10.1200/JCO.2015.64.8931


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/250585

Nanda, R., Chow, L. Q. M. L., Claire Dees, E., Berger, R., Gupta, S., Geva, R., Pusztai, L., Pathiraja, K., Aktan, G., Cheng, J. D., Karantza, V., & Buisseret, L. (2016). Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study. Journal of clinical oncology, 34(21), 2460-2467. doi:10.1200/JCO.2015.64.8931